Micron Capex Surge Bolsters LRCX Memory-Tailwind Thesis, but China Overhang Persists
Read source articleWhat happened
Micron Technology announced plans to significantly raise its capex this year, with another substantial jump in fiscal 2027, directly supporting Lam Research's revenue from memory equipment. Lam derives a significant portion of its revenue from selling memory manufacturing equipment, and the news reinforces the AI-driven DRAM investment cycle that has already driven Lam's recent growth. However, the DeepValue report maintains a WAIT rating on LRCX at $433, citing a concentrated China exposure (34-37% of revenue) that remains vulnerable to export licensing restrictions. The report's base case already embeds sustained memory spending, so the Micron news is incremental confirmation rather than a game-changer. The key watchpoints remain the June quarter print and any shift in China revenue share.
Implication
For investors, the Micron capex increase validates the AI-driven memory spend thesis, providing a near-term tailwind for Lam's equipment orders. However, the stock's current P/E of 81.5 already prices in a sustained upcycle, leaving little room for error. The DeepValue report's attractive entry is $360, implying a 17% downside from current levels; the Micron news alone does not justify chasing the stock at these multiples. Investors should wait for the June quarter results and clearer signals on China exposure before adding positions. If Lam can sustain revenue above $6.6B and keep China share stable, the stock could move toward the $440 base case, but the bear case of a China reset to $330 remains a 25% probability.
Thesis delta
The Micron capex news strengthens the memory tailwind leg of the bull case, but does not alter the fundamental risk from China exposure that underpins the WAIT rating. The thesis remains that a better entry point exists around $360, where the China risk is more adequately discounted. The upcoming June quarter results will be critical to confirm whether Lam can maintain its growth trajectory without a China-driven revenue hit.
Confidence
MEDIUM